Clin2
NCT05568498Possibly a fitRecruiting

Probiotic trial for depression in Parkinson’s disease

Parkinson DiseaseDepressionPARKINSON DISEASE (Disorder)

Part of Brain & nervous system clinical trials.

This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • A doctor has diagnosed Parkinson’s disease (not a similar condition) and you meet specific diagnostic standards
  • You are between 40 and 80 years old
  • Your Parkinson’s is mild to moderate (stage 1 to 3 while your symptoms are in the “ON” state)
  • Your depression is mild to moderate (Beck Depression Inventory score between 14 and 28 while in the “ON” state)
  • You can have screening tests in English, and you can follow the study for the full time (including keeping your usual activity level)
  • If you can become pregnant: you agree to reliable birth control and have a negative pregnancy test at screening and again at the start of the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06207136Recruiting
Diet and Gut Bacteria in Parkinson's

This study looks at how diet and the bacteria in your gut (microbiome) affect Parkinson's symptoms. You'll work with a coach and take cooking classes to see if changing what you eat can help you feel better.

Vancouver, British Columbia
NCT07610369Recruiting· Phase 2
Psilocybin therapy for depression in Parkinson's disease

This study tests whether psilocybin (a psychedelic compound) combined with therapy can reduce depression in people with Parkinson's disease. If you have moderate-to-severe depression and Parkinson's, this trial may offer a new treatment option.

New Haven, Connecticut
NCT07786116Recruiting
Gut bacteria in Parkinson's disease and related conditions

This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.

Cambridge, CB2
NCT07749261Not yet recruiting
Gut bacteria study for Parkinson's disease

This study looks at the germs in your gut and certain chemicals they make, which may relate to Parkinson's disease. It compares people with Parkinson's to healthy people of similar age and body size to see if there are differences.

Laizhou, Shandong
NCT06710574Recruiting· Phase 4
Probiotics for sleep problems in Parkinson's disease

This study tests whether taking probiotics can improve REM sleep behavior disorder (RBD) in people with Parkinson's disease. You will receive either a probiotic supplement or a placebo, and researchers will use brain scans to see how it affects your symptoms.

Beijing
NCT06455293Recruiting· Phase 2
Psilocybin therapy for depression in Parkinson's disease

This study tests whether psilocybin, a substance found in certain mushrooms, can help improve depression in people with Parkinson's disease. If you have Parkinson's and are feeling depressed, this treatment may offer a new option.

San Francisco, California

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.